Department of Urology, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1272, New York, NY, 10029, USA.
Department of Urology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.
World J Urol. 2022 Oct;40(10):2473-2479. doi: 10.1007/s00345-022-04105-0. Epub 2022 Jul 30.
Minimally invasive partial nephrectomy (MIPN) and radical nephrectomy (MIRN) have successfully resulted in shorter length of stay (LOS) for patients. Using a national cohort, we compared 30-day outcomes of SDD (LOS = 0) versus standard-length discharge (SLD, LOS = 1-3) for MIRN and MIPN.
All patients who underwent MIPN (CPT 50,543) or MIRN (CPT 50,545) in the ACS-NSQIP database from 2012 to 2019 were reviewed. SDD and SLD groups were matched 1:1 by age, sex, race, body mass index, American Society of Anesthesiologists score, and medical comorbidities. We compared baseline characteristics, 30-day Clavien-Dindo (CD) complications, reoperations, and readmissions between SDD and SLD groups. Multivariable logistic regressions were used to evaluate predictors of adverse outcomes.
28,140 minimally invasive nephrectomy patients were included (SDD n = 237 [0.8%], SLD n = 27,903 [99.2%]). There were no significant differences in 30-day readmissions, CD I/II, CDIII, or CD IV complications before and after matching SDD and SLD groups. On multivariate regression analysis, SDD did not confer increased risk of 30-day complications or readmissions for both MIPN and MIRN.
SDD after MIPN and MIRN did not confer increased risk of postoperative complications, reoperation, or readmission compared to SLD. Further research should explore optimal patient selection to ensure safe expansion of this initiative.
微创部分肾切除术(MIPN)和根治性肾切除术(MIRN)已成功缩短了患者的住院时间(LOS)。本研究使用全国性队列,比较了 MIRN 和 MIPN 中短 LOS(SDD,LOS=0)与标准 LOS(SLD,LOS=1-3)的 30 天结局。
回顾了 2012 年至 2019 年 ACS-NSQIP 数据库中接受 MIPN(CPT 50,543)或 MIRN(CPT 50,545)的所有患者。通过年龄、性别、种族、体重指数、美国麻醉医师协会评分和合并症对 SDD 和 SLD 组进行 1:1 匹配。比较了 SDD 和 SLD 组之间的基线特征、30 天 Clavien-Dindo(CD)并发症、再次手术和再入院情况。采用多变量逻辑回归评估不良结局的预测因素。
纳入了 28140 例微创肾切除术患者(SDD 组 n=237[0.8%],SLD 组 n=27903[99.2%])。在匹配 SDD 和 SLD 组前后,30 天内再入院、CD I/II、CDIII 或 CDIV 并发症的发生率无显著差异。多变量回归分析显示,SDD 并未增加 MIPN 和 MIRN 患者 30 天并发症或再入院的风险。
与 SLD 相比,MIPN 和 MIRN 后 SDD 并未增加术后并发症、再次手术或再入院的风险。进一步的研究应探索最佳的患者选择,以确保该方案的安全扩展。